Limits...
Prostatic urethral lift: A minimally invasive treatment for benign prostatic hyperplasia.

Garcia C, Chin P, Rashid P, Woo HH - Prostate Int (2015)

Bottom Line: Furthermore, improvement in LUTS may be attained while preserving erectile and ejaculatory function.Adverse effects associated with the PUL procedure are mild to moderate, and are transient in nature.The PUL procedure provides an alternative for men seeking treatment for bothersome LUTS, with fewer side-effects.

View Article: PubMed Central - PubMed

Affiliation: Sydney Adventist Hospital Clinical School, University of Sydney, NSW, Australia.

ABSTRACT
Prostatic urethral lift (PUL) is a minimally invasive procedure for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia. The procedure may be performed under local, spinal, or general anesthesia. The PUL procedure involves the delivery of implants that retract obstructing prostate lobes. Unlike other benign prostatic hyperplasia treatment options including pharmacological therapy, and the current invasive gold-standard transurethral resection of the prostate, the PUL procedure achieves quantifiable improvements in functional outcomes and quality of life, in the absence of major adverse events. Furthermore, improvement in LUTS may be attained while preserving erectile and ejaculatory function. Adverse effects associated with the PUL procedure are mild to moderate, and are transient in nature. The PUL procedure provides an alternative for men seeking treatment for bothersome LUTS, with fewer side-effects.

No MeSH data available.


Related in: MedlinePlus

The Urolift system comprising customizable nylon sutures and the suture delivery device which is introduced under cystoscopic guidance. Images copyright NeoTract, Inc., Pleasanton, CA, USA.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4494639&req=5

fig1: The Urolift system comprising customizable nylon sutures and the suture delivery device which is introduced under cystoscopic guidance. Images copyright NeoTract, Inc., Pleasanton, CA, USA.

Mentions: PUL is performed using the Urolift device (NeoTract Inc., Pleasanton, CA, USA; Fig. 1). The procedure is performed endoscopically utilizing a 19F or 20F cystoscope sheath. The Urolift device is a custom designed disposable cartridge that accepts a 2.9-mm 0° 36-cm telescope lens. The cartridge is configured to deliver a single prosthesis that is constructed of a Capsular nitinol tab and a urethral stainless steel tab bridged by a nonabsorbable suture. The suture is under tension and draws the prostatic urethra to the prostate capsule.


Prostatic urethral lift: A minimally invasive treatment for benign prostatic hyperplasia.

Garcia C, Chin P, Rashid P, Woo HH - Prostate Int (2015)

The Urolift system comprising customizable nylon sutures and the suture delivery device which is introduced under cystoscopic guidance. Images copyright NeoTract, Inc., Pleasanton, CA, USA.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4494639&req=5

fig1: The Urolift system comprising customizable nylon sutures and the suture delivery device which is introduced under cystoscopic guidance. Images copyright NeoTract, Inc., Pleasanton, CA, USA.
Mentions: PUL is performed using the Urolift device (NeoTract Inc., Pleasanton, CA, USA; Fig. 1). The procedure is performed endoscopically utilizing a 19F or 20F cystoscope sheath. The Urolift device is a custom designed disposable cartridge that accepts a 2.9-mm 0° 36-cm telescope lens. The cartridge is configured to deliver a single prosthesis that is constructed of a Capsular nitinol tab and a urethral stainless steel tab bridged by a nonabsorbable suture. The suture is under tension and draws the prostatic urethra to the prostate capsule.

Bottom Line: Furthermore, improvement in LUTS may be attained while preserving erectile and ejaculatory function.Adverse effects associated with the PUL procedure are mild to moderate, and are transient in nature.The PUL procedure provides an alternative for men seeking treatment for bothersome LUTS, with fewer side-effects.

View Article: PubMed Central - PubMed

Affiliation: Sydney Adventist Hospital Clinical School, University of Sydney, NSW, Australia.

ABSTRACT
Prostatic urethral lift (PUL) is a minimally invasive procedure for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia. The procedure may be performed under local, spinal, or general anesthesia. The PUL procedure involves the delivery of implants that retract obstructing prostate lobes. Unlike other benign prostatic hyperplasia treatment options including pharmacological therapy, and the current invasive gold-standard transurethral resection of the prostate, the PUL procedure achieves quantifiable improvements in functional outcomes and quality of life, in the absence of major adverse events. Furthermore, improvement in LUTS may be attained while preserving erectile and ejaculatory function. Adverse effects associated with the PUL procedure are mild to moderate, and are transient in nature. The PUL procedure provides an alternative for men seeking treatment for bothersome LUTS, with fewer side-effects.

No MeSH data available.


Related in: MedlinePlus